Literature DB >> 8146655

Binding and suppression of the Myc transcriptional activation domain by p107.

W Gu1, K Bhatia, I T Magrath, C V Dang, R Dalla-Favera.   

Abstract

An amino-terminal transactivation domain is required for Myc to function as a transcription factor controlling cell proliferation, differentiation, and apoptosis. A complementary DNA expression library was screened with a Myc fusion protein to identify proteins interacting with this domain, and a clone encoding the Rb-related p107 protein was isolated. The p107 protein was shown to associate with Myc in vivo and to suppress the activity of the Myc transactivation domain. However, mutant forms of Myc from Burkitt lymphoma cells, which contain sequence alterations in the transactivation domain, were resistant to p107-mediated suppression. Thus, disruption of a regulatory interaction between Myc and p107 may be important in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8146655     DOI: 10.1126/science.8146655

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  58 in total

1.  The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.

Authors:  D W Chang; G F Claassen; S R Hann; M D Cole
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1.

Authors:  A Bellacosa; L Cicchillitti; F Schepis; A Riccio; A T Yeung; Y Matsumoto; E A Golemis; M Genuardi; G Neri
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  A role for c-myc in chemically induced renal-cell death.

Authors:  Y Zhan; J L Cleveland; J L Stevens
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

Authors:  C Cinti; L Leoncini; A Nyongo; F Ferrari; S Lazzi; C Bellan; R Vatti; A Zamparelli; G Cevenini; G M Tosi; P P Claudio; N M Maraldi; P Tosi; A Giordano
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

5.  The transactivation potential of a c-Myc N-terminal region (residues 92-143) is regulated by growth factor/Ras signaling.

Authors:  M S Colman; M C Ostrowski
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

6.  Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.

Authors:  K Alevizopoulos; J Vlach; S Hennecke; B Amati
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

7.  Molecular cloning, expression and chromosomal localization of mouse MM-1.

Authors:  Tetsuya Inazu; Zaw Myint; Asato Kuroiwa; Yoichi Matsuda; Tamio Noguchi
Journal:  Mol Biol Rep       Date:  2005-12       Impact factor: 2.316

8.  A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene, MODY1, and a myeloid leukemia related gene.

Authors:  M Stoffel; M M Le Beau; R Espinosa; S F Bohlander; D Le Paslier; D Cohen; K S Xiang; N J Cox; S S Fajans; G I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

9.  Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis.

Authors:  B Lutterbach; S R Hann
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  Glycosylation of the c-Myc transactivation domain.

Authors:  T Y Chou; C V Dang; G W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.